Apogee Therapeutics (APGE) Q2 2024 Earnings

13MayConfirmed
Q4 2023
Q2 2024
-0.65
-0.63
-0.61
-0.59

Details

Expected EPS
-0.586667
Actual EPS
-0.64
Surprise EPS
-0.05
Surprise Percent
+9.09%

Description

Apogee Therapeutics (APGE) has reported earnings of -0.64 per share for Q2 2024.

0 Comments

Share your thoughts